Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura.
Pool
V
V
Centers for Disease Control and Prevention Atlanta, GA, USA.
Chen
R
R
Rhodes
P
P
D000914:Antibodies, Viral / Q000276:immunology; D002648:Child; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008458:Measles Vaccine / Q000009:adverse effects* / Q000276:immunology*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000009:adverse effects* / Q000276:immunology*; D012307:Risk Factors; D012409:Rubella / Q000453:epidemiology; D012411:Rubella Vaccine / Q000009:adverse effects* / Q000276:immunology*; D012412:Rubella virus / Q000276:immunology; D013921:Thrombocytopenia / Q000175:diagnosis* / Q000276:immunology*; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000009:adverse effects*; D014613:Vaccines, Attenuated / Q000009:adverse effects* / Q000276:immunology*; D017778:Vaccines, Combined / Q000009:adverse effects / Q000276:immunology
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined